Author:
Chen Zhangbin,Ma Yifei,Guo Zhitang,Song Dingyuan,Chen Zili,Sun Min
Funder
Guizhou Medical University
Subject
Hepatology,General Medicine
Reference30 articles.
1. Epidemiology and surveillance for hepatocellular carcinoma: New trends;Singal;J Hepatol,2020
2. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet (London, England),2018
3. Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?;Rizzo;Expert Opin Investig Drugs,2021
4. Immune checkpoint inhibitors in melanoma;Carlino;Lancet (London, England),2021
5. Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma;Rizzo;Cancer Treat Res Commun,2021
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献